Lannett Company, Inc.
https://www.lannett.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Lannett Company, Inc.
Relying On Perfection In An Imperfect World: ADHD Drug Shortage Could Spur Push For DEA Reform
Ongoing stimulant shortages leads to calls for DEA to allow for more elasticity in the supply chains of drugs with potential for abuse, but in wake of ongoing opioid crisis agency appears willing to potentially shift but not up quotas.
Cipla Rides High Amid US Market Shakeout
Cipla reports highest ever quarterly revenues in the US, a market that’s seeing lower “price compression” amid sell-offs, bankruptcies and a rebalancing of the supply chain. The firm’s portfolio has a “lot of steam” left to be unlocked and it’s also keeping an eye on the impact of the tornado-hit Pfizer site on supplies.
Cipla Rides High Amid US Market Shakeout
Cipla reports highest ever quarterly revenues in the US, a market that’s seeing lower “price compression” amid sell-offs, bankruptcies and a rebalancing of the supply chain. The firm’s portfolio has a “lot of steam” left to be unlocked and it’s also keeping an eye on the impact of the tornado-hit Pfizer site on supplies.
Cipla's Advair Generic US Debut May Be Pushed Out But 'Value Intact'
Cipla to pursue two-site, de-risked filing approach for large respiratory assets even as it awaits an FDA compliance classification for its Indore facility, which will determine the launch timelines for its much-awaited generic Advair in the US.
Company Information
- Industry
-
Pharmaceuticals
- Generic Drugs
- Other Names / Subsidiaries
-
- Kremers Urban Pharmaceuticals, Cody Laboratories, Silarx Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice